The development of DNA-biochips for rational prescribing of psychologists (Q11681)

From EU Knowledge Graph
Revision as of 19:05, 17 February 2020 by DG Regio (talk | contribs) (‎Changed an Item: Label in wikidata changed)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
The development of DNA-biochips for rational prescribing of psychologists
Project in Czech Republic financed by DG Regio

    Statements

    country
    Czechia
    0 references
    EU contribution
    7,740,698.73 Czech koruna
    0 references
    309,627.94920000003 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    11,073,961.0 Czech koruna
    0 references
    442,958.44 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    69.8999999187283 percent
    0 references
    expected end time
    31 October 2020
    0 references
    beneficiary name (string)
    ESSENCE LINE, s.r.o.
    0 references
    beneficiary
    ESSENCE LINE
    0 references
    coordinate location

    50°4'11.50"N, 14°22'51.56"E
    0 references

    50°4'6.46"N, 14°23'8.41"E
    0 references
    postal code
    15000
    0 references
    15000
    0 references
    summary
    Cílem projektu je vyvinout nový DNA-biochip pro racionalizovanou preskripci psychofarmak pro pacienty s psychiatrickým onemocněním a tím přinést prospěch nejen pacientovi, ale snížit náklady zdravotních pojišťoven. Přínosem projektu bude bezpečnější a efektivnější preskripce psychofarmak, což povede k úspěšnější farmakoterapii, zvýší komfort pacienta v podobě pozitivní terapie a sníží náklady na neefektivně aplikovaná psychofarmaka a negativní dopady na pacienta. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/17_107/0012433
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11681&oldid=667707"